A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01177163 · COMPLETED
Trial details
- NCT number
- NCT01177163
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.